VeriSign, Inc. filings document the company’s domain name registry business, quarterly operating results, governance matters, and capital-structure disclosures. Form 8-K reports include financial results for the .com and .net registry operator, statements affecting the domain name base, and updates on dividends and other material events.
Proxy materials cover board elections, executive compensation, shareholder voting matters, and director governance. Other filings describe board changes, senior notes-related non-guarantor subsidiary financial information, and formal disclosures for a public company that provides DNS infrastructure, root zone maintainer services, and authoritative resolution for major top-level domains.
VeriSign, Inc. (VRSN) officer Thomas Christopher Indelicarto reported a proposed sale of 498 common shares, with an aggregate market value of $136,452.00 and an approximate sale date of April 7, 2026. The reported Rule 10b5-1 plan adoption date is February 18, 2025. The 498 shares were acquired from the issuer as performance shares on February 5, 2026.
VeriSign Inc filing shows The Vanguard Group amended its Schedule 13G report following an internal realignment and disaggregation of certain subsidiaries. The filing states amount beneficially owned: 0 shares and percent of class: 0% as of the amendment. The amendment cites SEC Release No. 34-39538 (January 12, 1998) and explains that certain subsidiaries will report beneficial ownership separately after Vanguard's internal realignment on January 12, 2026. The filing is signed by Ashley Grim on 03/27/2026.
Verisign executive Thomas C. Indelicarto, EVP, General Counsel & Secretary, reported an open-market sale of 498 shares of Verisign common stock at $250.00 per share on March 25, 2026. After this transaction, he directly holds 39,198.258 Verisign shares, indicating this was a relatively small sale compared to his remaining stake.
Armstrong Courtney D reported open-market purchase transactions in this Form 4 filing.
VERISIGN INC/CA director Courtney D. Armstrong reported a small increase in his holdings. A trust associated with him, The Armstrong Family Trust, acquired 15.909 shares of common stock at $250.17 per share through the reinvestment of dividends.
Following this dividend reinvestment, Armstrong’s indirect ownership stands at 5,203.471 shares held by the trust, and he also holds 882.244 shares directly. This filing reflects a routine, incremental increase in his overall position rather than a large discretionary trade.
VeriSign, Inc. affiliate Thomas C. Indelicarto filed Form 144 reporting proposed sales of Common shares, with multiple transactions listed in early 2026. The excerpt shows several sales (for example, 332 shares for $79,885.84 on 03/10/2026 and 498 shares for $115,426.44 on 03/03/2026). Shares outstanding were 91,700,000 as of 03/25/2026; this is a baseline figure, not the amount being offered.
Verisign EVP, General Counsel & Secretary Thomas C. Indelicarto sold 332 shares of Verisign common stock in an open-market transaction on March 10, 2026 at $240.62 per share. After this sale, he directly owns 39,696.258 shares of Verisign common stock.
VeriSign, Inc. officer Thomas Christopher Indelicarto intends to sell 332 shares of common stock, with an aggregate market value of $79,885.84 and an approximate sale date of March 10, 2026. He acquired the shares from the issuer as performance shares on February 5, 2026. If relying on Rule 10b5-1, the stated date of plan adoption or instruction is February 18, 2025.
Verisign executive Thomas C. Indelicarto reported open-market sales of company stock. On March 3, 2026, he sold 332 shares of Verisign common stock at $235.00 per share and 166 shares at $225.34 per share, totaling 498 shares.
After these transactions, his directly held Verisign common stock stood at 40,028.258 shares. This amount includes 76.4472 dividend equivalent restricted stock units acquired on February 27, 2026 in respect of previously granted restricted stock units under the company’s equity incentive plan.
VeriSign, Inc. (VRSN) officer Thomas Christopher Indelicarto gave notice of a proposed sale of 498 common shares, with an aggregate market value of $115,426.44 and an approximate sale date of March 3, 2026. The shares were acquired from the issuer as performance shares on February 5, 2026. The proposed sale’s reported Rule 10b5-1 plan adoption or instruction date is February 18, 2025.
Verisign director Courtney D. Armstrong reported two open-market purchases of Verisign common stock. One transaction was an indirect purchase of 18.787 shares at $223.54 per share held by The Armstrong Family Trust, and the other was a direct purchase of 3.244 shares at $219.44 per share.